Effectiveness of Lipid Lowering Therapies in Diabetes
Author Information
Author(s): Eliasson Björn, Svensson Ann-Marie, Miftaraj Mervete, Miao Jonasson Junmei, Eeg-Olofsson Katarina, Andersson Sundell Karolina, Gudbjörnsdóttir Soffia
Primary Institution: Department of Medicine, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden
Hypothesis
To describe the use and evaluate the effectiveness of different lipid lowering therapies in unselected patients with type 1 and type 2 diabetes in clinical practice.
Conclusion
The study found that LDL-C levels in patients taking simvastatin, atorvastatin, or rosuvastatin are very similar, indicating a potential to intensify lipid lowering treatment to reduce residual risk.
Supporting Evidence
- Patients treated with simvastatin, atorvastatin, and rosuvastatin showed similar LDL-C lowering effects.
- 76% of simvastatin users took 20 mg or less, indicating low to moderate dosing.
- Around two-thirds of patients reached the LDL-C target of <2.5 mmol/L.
Takeaway
This study looked at how well different cholesterol-lowering medicines work for people with diabetes, finding that many patients aren't getting enough help to lower their cholesterol.
Methodology
Observational population-based study using data from the National Diabetes Register and other national registers in Sweden.
Potential Biases
There may be selection effects due to the criteria for including patients in the study.
Limitations
The study results should be interpreted with caution due to possible selection effects and minor errors in clinical characteristics.
Participant Demographics
Mean age was around 62 years, with approximately 60% men and 10% having type 1 diabetes.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website